Day: May 31, 2022

Permex Petroleum Reports Second Quarter Fiscal Year 2022 Financial Results

Permex Petroleum Reports Second Quarter Fiscal Year 2022 Financial Results

VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) — Permex Petroleum Corporation (CSE: OIL) (OTCQB: OILCF) (FSE: 75P) (“Permex” or the “Company“), a uniquely-positioned junior oil and gas company, is pleased to report financial results for the three and six-months ended March 31, 2022 and provide a corporate update. Recent Company Highlights Revenue of $288,238 and $401,614 for the three and six months ended March 31, 2022, respectively Completed the re-entry of two previously shut-in oil well on its West Henshaw property in Eddy County, New Mexico Completed a brokered private placement for gross proceeds of approximately CAD$9.4 million Appointed Mr. Greg Montgomery as Chief Financial Officer and Corporate Secretary of the Company Management Commentary “We are reaching an inflection point in...

Continue reading

JOYY Reports First Quarter 2022 Unaudited Financial Results

JOYY Reports First Quarter 2022 Unaudited Financial Results

SINGAPORE, June 01, 2022 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: YY) (“JOYY” or the “Company”, formerly known as YY Inc.), a global video-based social media company, today announced its unaudited financial results for the first quarter of 2022. First Quarter 2022 Financial Highlights1 Net revenues were US$623.8 million, compared to US$643.1 million in the corresponding period of 2021. Net loss from continuing operations attributable to controlling interest of JOYY2 was US$27.5 million, compared to net loss of US$87.3 million in the corresponding period of 2021, primarily as a result of BIGO turning profits since the second quarter of 2021. Non-GAAP net income from continuing operations attributable to controlling interest and common shareholders of JOYY3 was US$20.9 million, compared to non-GAAP net loss of US$24.1 million in the...

Continue reading

Bunker Hill Announces Receipt for Final Short-Form Canadian Prospectus and Effectiveness of US Registration Statement for Special Warrant Offering

Bunker Hill Announces Receipt for Final Short-Form Canadian Prospectus and Effectiveness of US Registration Statement for Special Warrant Offering

Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, May 31, 2022 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR; OTCQB: BHLL) is pleased to announce that the Company received a receipt today from the Ontario Securities Commission for its final short-form Canadian prospectus (the “Prospectus”) qualifying the distribution of the common stock of the Company (“Common Shares”) and common stock purchase warrants of the Company (“Warrants”) issuable upon exercise of the special warrants of the Company (“Special Warrants”) that were issued on April 1, 2022. The Company is also pleased to announce that it received notice from the United States Securities and Exchange Commission that its Form S-1 has...

Continue reading

Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Announces Move Toward Regulatory Submission Following Initial Data From LUCIDITY Trial

Dundee Corporation Portfolio Holding, TauRx Pharmaceuticals Ltd., Announces Move Toward Regulatory Submission Following Initial Data From LUCIDITY Trial

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announces that TauRx Pharmaceuticals Ltd. (“TauRx”), a leader in tau-based research in Alzheimer’s, unveiled initial data from the randomised portion of their widely followed Phase 3 clinical trial, LUCIDITY (NCT03446001). Dundee holds 1,015,008 shares in TauRx. For a copy of TauRx’s official announcement, please visit: https://ts-assets.ams3.cdn.digitaloceanspaces.com/mg/tx/pdfs/Lucidity-Data-Announcement.31May2022.for-website.pdf TauRx Announcement Highlights: LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (“HMTM”) decline at a rate substantially less than is typical in Alzheimer’s based on published research. Safety profile is favourable and consistent with previous HMTM studies. TauRx...

Continue reading

1stDibs to Participate in Upcoming Investor Conference

1stDibs to Participate in Upcoming Investor Conference

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) — 1stdibs.com, Inc. (Nasdaq: DIBS), a leading online marketplace for luxury design products, announced today that CEO David Rosenblatt and CFO Tom Etergino will present at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6th at 1:40pm ET. A live webcast and replay of these sessions will be featured on the company’s Investor Relations website (investors.1stdibs.com). About 1stDibs1stDibs is a leading online marketplace for connecting design lovers with highly coveted sellers and makers of vintage, antique, and contemporary furniture, home décor, art, jewelry, watches and fashion. Investor Relations Contact:Kevin LaBuz, Head of Investor Relationsinvestors@1stDibs.com Media Contact:Jennifer Millerjennifer.miller@1stdibs.com

Continue reading

Trailbreaker Resources Grants Stock Options

Trailbreaker Resources Grants Stock Options

VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) announces that subject to all regulatory approvals, the Company has granted 785,000 incentive stock options to directors, officers, and certain consultants of the Company. All Options issued pursuant to this grant shall vest immediately, have a term of 5 years and are exercisable at $0.24. ON BEHALF OF THE BOARD Daithi Mac GearailtPresident and Chief Executive Officer For new information about the Company’s projects, please visit Trailbreaker’s website at TrailbreakerResources.com and sign up to receive news. For further information, follow Trailbreaker’s tweets at Twitter.com/TrailbreakerLtd, use the ‘Contact’ section of our website, or contact us at (604) 681-1820 or at info@trailbreakerresources.com. Neither...

Continue reading

Wesana Announces First Quarter 2022 Financial Results

Wesana Announces First Quarter 2022 Financial Results

CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has today announced its first quarter 2022 financial results. Q1 2022 Highlights Delivered findings indicating psilocybin potentiates impact of anti-depressant Received positive feedback from pre-Investigational New Drug (“IND”) meeting with U.S. Food and Drug Administration (“FDA”) on SANA-013 Announced positive findings from Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol Record Q1 2022 operating results at Wesana Clinics Opening of third Wesana Clinic in May 2022 Launched strategic Review of Care Delivery Assets Select Consolidated...

Continue reading

Epsilon Energy Ltd. Announces the Following Headlines

Epsilon Energy Ltd. Announces the Following Headlines

Board declares dividend of $0.0625 per common share Repurchased 259,300 shares during the quarter Oklahoma production project exceeding expectations Outlook for FCF generation remains favorable HOUSTON, May 31, 2022 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced that its Board of Directors has declared a dividend of $0.0625 per share of common stock (annualized $0.25/sh) to the stock holders of record at the close of business on June 15th 2022, payable on June 30th 2022. All dividends paid by the Company are “eligible dividends” as defined in subsection 89(1) of the Income Tax Act (Canada), unless indicated otherwise. In addition the Company repurchased 259,300 shares for $1.8 MM (approximately $7/share) during the quarter (through May 27, 2022). The company is authorized to...

Continue reading

Toll Brothers Apartment Living® and PGIM Real Estate Announce Joint Venture to Develop 432-Unit Luxury Rental Community in Boston, Massachusetts

Toll Brothers Apartment Living® and PGIM Real Estate Announce Joint Venture to Develop 432-Unit Luxury Rental Community in Boston, Massachusetts

JV Secures $226 Million Construction Loan from Wells Fargo N.A., BNY Mellon, and The Bank of East Asia, Limited, New York Branch Lyra Boston, MA FORT WASHINGTON, Pa., May 31, 2022 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, through its Toll Brothers Apartment Living® rental division, and PGIM Real Estate, the real estate investment and financing business of PGIM, the $1.5 trillion global asset management business of Prudential Financial (NYSE: PRU) have announced another new joint venture to develop Lyra, a 34-story, 432-unit multifamily rental community in downtown Boston, MA. The project, which will be the first development by Toll Brothers Apartment Living (TBAL) in Boston, is being financed through a $226 million construction loan facility from Wells...

Continue reading

Hepion Pharmaceuticals Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting

Hepion Pharmaceuticals Urges Shareholders to Vote “FOR” All Proposals Ahead of its Upcoming Annual Meeting

EDISON, N.J., May 31, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and hepatocellular carcinoma (“HCC”), today urged its stockholders to vote “FOR” all proposals put forth in the definitive proxy statement prior to its June 24, 2022 Annual Meeting of Stockholders. “As one equity analyst recently observed in a research note, our industry is facing one of the worst biotech tapes in a generation,” said Dr. Robert Foster, PharmD, PhD, Hepion’s CEO. “Indeed, since the market peaked in February 2021, the aggregate enterprise value of the world’s biotech sector is down approximately 50%, and over one-half of individual biotech sector...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.